Russell Frank Company’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Russell Frank Company’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-318	Closed	-$718K	–	3101
2015 Q1	$718K	Buy	+318	New	+$542K	﹤0.01%	2296
2014 Q1	–	Sell	-172	Closed	-$441K	–	2895
2013 Q4	$441K	Buy	172 +171	+17,100%	+$404K	﹤0.01%	2383
2013 Q3	$2K	Hold	1	–	–	﹤0.01%	3367
2013 Q2	$2K	Buy	+1	New	+$1.59K	﹤0.01%	3185

Other funds holding AMPE

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NFG

Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Russell Frank Company's AMPE Position: Q2 2015 in Review

Russell Frank Company sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2015, closing a stake of 318 shares — an estimated $718K sold.

Russell Frank Company first reported a position in AMPE in Q2 2013 and held it in 4 quarters. The position peaked at $718K in Q1 2015. 64 funds tracked by Wall St. Rank hold AMPE as of Q2 2015.

Russell Frank Company reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2015 after selling out during the quarter.
Russell Frank Company sold 318 Ampio Pharmaceuticals Inc. shares in Q2 2015, an estimated $718K.
Russell Frank Company first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 4 quarters.
Russell Frank Company's Ampio Pharmaceuticals Inc. position peaked at $718K in Q1 2015.
64 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2015.

Based on Russell Frank Company's 13F filing for Q2 2015, filed 13 Aug 2015.